Ischemia is a multifactorial pathology characterized by different events evolving in the time. After ischemia, primary damage due to the early massive increase of extracellular glutamate is followed by activation of resident immune cells, i.e., microglia, and production or activation of inflammation mediators. Protracted neuroinflammation is now recognized as the predominant mechanism of secondary brain injury progression. Extracellular concentrations of adenosine in the brain increase dramatically during ischemia at levels able to stimulate all (A1, A2A, A2B and A3) receptors. Although adenosine exerts a clear neuroprotective effect through A1 receptors during ischemia, the use of selective A1 agonists is hampered by undesirable peripheral effects. Evidence up to now in the literature indicates that A2A receptor antagonists provide protection centrally by reducing excitotoxicity, while agonists at A2A (and possibly also A2B) and A3 receptors provide protection by controlling massive infiltration and neuroinflammation in the hours and days after brain ischemia.

Adenosine and Oxygen/Glucose Deprivation in the Brain / Pedata, Felicita; Dettori, Ilaria; Fusco, Irene; Coppi, Elisabetta; Pugliese, Anna M.; Melani, Alessia. - STAMPA. - (2017), pp. 151-173. [10.1016/B978-0-12-803724-9.00008-9]

Adenosine and Oxygen/Glucose Deprivation in the Brain

Pedata, Felicita;Dettori, Ilaria;Fusco, Irene;Coppi, Elisabetta;Pugliese, Anna M.;Melani, Alessia
2017

Abstract

Ischemia is a multifactorial pathology characterized by different events evolving in the time. After ischemia, primary damage due to the early massive increase of extracellular glutamate is followed by activation of resident immune cells, i.e., microglia, and production or activation of inflammation mediators. Protracted neuroinflammation is now recognized as the predominant mechanism of secondary brain injury progression. Extracellular concentrations of adenosine in the brain increase dramatically during ischemia at levels able to stimulate all (A1, A2A, A2B and A3) receptors. Although adenosine exerts a clear neuroprotective effect through A1 receptors during ischemia, the use of selective A1 agonists is hampered by undesirable peripheral effects. Evidence up to now in the literature indicates that A2A receptor antagonists provide protection centrally by reducing excitotoxicity, while agonists at A2A (and possibly also A2B) and A3 receptors provide protection by controlling massive infiltration and neuroinflammation in the hours and days after brain ischemia.
2017
9780128037454
Adenosine Receptors in Neurodegenerative Diseases
151
173
Pedata, Felicita; Dettori, Ilaria; Fusco, Irene; Coppi, Elisabetta; Pugliese, Anna M.; Melani, Alessia
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1109461
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact